Home » Stocks » Cantel Medical

Cantel Medical Corporation (CMD)

Stock Price: $49.26 USD 1.05 (2.18%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.08B
Revenue (ttm) 1.02B
Net Income (ttm) 28.12M
Shares Out 42.15M
EPS (ttm) 0.67
PE Ratio 73.52
Forward PE 26.11
Dividend $0.21
Dividend Yield 0.43%

Stock Quote

Trading Day Aug 4, 2020
Last Price $49.26
Previous Close $48.21
Change ($) 1.05
Change (%) 2.18%
Day's Open 48.29
Day's Range 47.97 - 49.55
Day's Volume 203,095
52-Week Range 20.81 - 93.62

More Stats

Market Cap 2.08B
Enterprise Value 2.99B
Earnings Date (est) Sep 24, 2020
Ex-Dividend Date n/a
Shares Outstanding 42.15M
Float 36.89M
EPS (basic) 0.67
EPS (diluted) 0.67
FCF / Share 1.54
Dividend $0.21
Dividend Yield 0.43%
Earnings Yield 1.36%
FCF Yield 3.13%
Payout Ratio 30.60%
Shares Short 4.29M
Short Ratio 5.95
Short % of Float 11.43%
Beta 1.26
PE Ratio 73.52
Forward PE 26.11
P/FCF Ratio 31.93
PS Ratio 2.03
PB Ratio 2.89
Revenue 1.02B
Operating Income 59.30M
Net Income 28.12M
Free Cash Flow 65.03M
Net Cash -911.63M
Net Cash / Share -21.63
Gross Margin 42.09%
Operating Margin 5.80%
Profit Margin 2.80%
FCF Margin 6.36%
ROA 4.90%
ROE 4.18%
ROIC 4.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 2
Overweight 1
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$65.00*
(31.95% upside)
Low
65.0
Current: $49.26
High
65.0
Target: 65.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue918872770665565489425386322274
Revenue Growth5.3%13.21%15.86%17.65%15.6%14.99%9.97%20.16%17.41%-
Gross Profit427414367309253213183164123111
Operating Income83.5212211097.2580.7670.9363.1951.5231.3432.67
Net Income55.0491.0471.3859.9547.9543.2739.2431.3420.4319.94
Shares Outstanding41.7741.7141.7241.7041.5541.3841.0840.5038.7237.92
Earnings Per Share1.322.181.711.441.151.040.950.770.520.52
EPS Growth-39.45%27.49%18.75%25.22%10.58%9.47%23.38%48.08%0%-
Dividend Per Share0.200.170.140.120.100.090.070.060.050.04
Dividend Growth17.65%21.43%16.67%20%11.11%21.62%19.35%16.98%20.45%-
Operating Cash Flow66.9312610880.2759.0764.2751.4950.5828.2029.03
Capital Expenditures-95.44-37.70-27.02-18.79-12.74-13.53-6.71-5.49-5.76-5.60
Free Cash Flow-28.5188.2181.1861.4846.3450.7544.7845.0922.4423.43
Cash & Equivalents44.5494.1036.5828.3731.7231.7834.0830.1918.4122.61
Total Debt23119712611678.5080.5095.0090.0024.0021.00
Net Cash / Debt-186-103-89.42-87.63-46.78-48.72-60.92-59.81-5.591.61
Assets1,070964786695584536488435321281
Liabilities40935526224017717116715987.1371.26
Book Value662609524454407365321276234209
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cantel Medical Corporation
Country United States
Employees 2,775
CEO George L. Fotiades

Stock Information

Ticker Symbol CMD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: CMD

Description

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers. The company's Dental segment offers biological indicators, chemical integrators, sterilization pouches, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, amalgam separators, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.